This website is part of the ECDC (European Centre for Disease Prevention and Control) network
ECDC logo
Contact Sitemap Links RSS feeds
Font:
Accessibility
 
European Center for Disease Prevention and Control






Go to extranet
   
Skip Navigation Links
Home
About Us
Activities
Health Topics
Publications
Media Centre
You are here: Skip Navigation LinksECDC Portal > English > Health Topics > Hepatitis B

 HEALTH TOPICS A-Z

Click a letter to see health topics

 READ MORE ON ECDC SITE

 EUROSURVEILLANCE

 ESCAIDE PRESENTATIONS

 RELATED HEALTH TOPICS

 
Skip navigation links
Basic facts
Epidemiological data
Hepatitis B 

Hepatitis B is caused by hepatitis B virus. Hepatitis B can be either without symptoms or acute or chronic symptomatic infection. The incubation period is long - up to six months (or even longer). Acute illness ranges from a mild to a very severe disease. Hepatitis B in children usually goes with no symptoms, with a higher tendency to become chronic. Conversely, the death rate of acute infection can reach 2% in the elderly. NEW

Those who become chronically infected by hepatitis B virus (from >30% among children to <5% among adults) are at a higher risk of serious consequences: liver cirrhosis (25%) and cancer (5%). Moreover, they act as a reservoir for continuing disease transmission. In recent years, increasing numbers of drugs are becoming available for treatment of chronic infection.

Hepatitis B is transmitted via contact (broken skin or mucosal contact) with blood or other body fluids (serum, semen, saliva) from infected patients. Chronic carriers usually remain infectious throughout their life. The incubation period ranges from one to seven months.

For infants and children, the main source of infection is mother-to-child transmission and transmission from infected members within the household. Adolescents and adults normally become infected through unprotected sexual activity or as a consequence of injecting drug users sharing contaminated needles. Transmission via blood transfusion or through the use of plasma-derived products is now rare in the EU.

Hepatitis B occurs worldwide with a very high burden of disease (an estimated 280 million carriers worldwide). HBV vaccination is currently the most effective way to prevent HBV infection.

Read more about hepatitis B in the factsheet for general public.


 IN THIS SECTION


Basic facts
Factsheet for the general public

Epidemiological data
Annual epidemiological report: Hepatitis B

 FEATURED PUBLICATIONS

Annual Epidemiological Report 2012
Scientific Publication - Mar 2013
See chapter 2.2 Sexually transmitted infections, including HIV and blood-borne viruses
   Share